Publication | Closed Access

High-Dose-Rate Brachytherapy as Monotherapy Delivered in Two Fractions Within One Day for Favorable/Intermediate-Risk Prostate Cancer: Preliminary Toxicity Data

UrologyRadiation TherapyFavorable/intermediate-risk Prostate CancerMedicineBrachytherapyProstatic DiseaseOncologyRadiation OncologyHigh-dose-rate BrachytherapyPreliminary Toxicity Data